Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.11 Million ≈ $6.60 Million USD) by net assets (CN¥1.88 Billion ≈ $274.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 605016 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Poly Plastic Masterbatch Suzhou Co
SHE:300905
|
0.031x |
|
Xinjiang Zhongtai Chemical Co Ltd
SHE:002092
|
0.069x |
|
Alkane Resources Ltd
AU:ALK
|
0.156x |
|
Yinbang Clad Material
SHE:300337
|
-0.039x |
|
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
|
-0.072x |
|
Vaisala Oyj A
HE:VAIAS
|
0.050x |
|
Triumph Financial, Inc.
NYSE:TFIN
|
0.005x |
|
Yutong Optical
SHE:300790
|
0.026x |
Annual Cash Flow Conversion Efficiency for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Shandong Bailong Chuangyuan Bio-Tech Co. market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.96 Billion ≈ $287.02 Million |
CN¥135.45 Million ≈ $19.82 Million |
0.069x | -61.46% |
| 2024-12-31 | CN¥1.68 Billion ≈ $245.73 Million |
CN¥300.89 Million ≈ $44.03 Million |
0.179x | +38.81% |
| 2023-12-31 | CN¥1.51 Billion ≈ $220.64 Million |
CN¥194.63 Million ≈ $28.48 Million |
0.129x | +15.88% |
| 2022-12-31 | CN¥1.34 Billion ≈ $196.81 Million |
CN¥149.82 Million ≈ $21.92 Million |
0.111x | +39.36% |
| 2021-12-31 | CN¥1.20 Billion ≈ $176.10 Million |
CN¥96.20 Million ≈ $14.08 Million |
0.080x | -54.65% |
| 2020-12-31 | CN¥691.09 Million ≈ $101.13 Million |
CN¥121.82 Million ≈ $17.83 Million |
0.176x | +64.25% |
| 2019-12-31 | CN¥597.07 Million ≈ $87.37 Million |
CN¥64.08 Million ≈ $9.38 Million |
0.107x | -39.58% |
| 2018-12-31 | CN¥501.71 Million ≈ $73.42 Million |
CN¥89.12 Million ≈ $13.04 Million |
0.178x | -31.68% |
| 2017-12-31 | CN¥436.41 Million ≈ $63.86 Million |
CN¥113.47 Million ≈ $16.60 Million |
0.260x | +56.90% |
| 2016-12-31 | CN¥362.67 Million ≈ $53.07 Million |
CN¥60.10 Million ≈ $8.79 Million |
0.166x | -- |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more